New surface radiolabeling schemes of super paramagnetic iron oxide nanoparticles (SPIONs) for biodistribution studies

Nanoscale

Volumn 7, Issue 15, 2015, Pages 6545-6555

  Nallathamby, Prakash D ^a,b,d   Mortensen, Ninell P ^b   Palko, Heather A ^a,c   Malfatti, Mike ^c   Smith, Catherine ^a   Sonnett, James ^a   Doktycz, Mitchel J ^b   Gu, Baohua ^b   Roeder, Ryan K ^d   Wang, Wei ^b   Retterer, Scott T ^b  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b OAK RIDGE NATIONAL LABORATORY   (United States)

^c LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^d University of Notre Dame   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL DETECTION; DRUG DELIVERY; DYNAMIC LIGHT SCATTERING; FLUID DYNAMICS; FUNCTIONAL GROUPS; HYDRODYNAMICS; IRON; LIGHT SCATTERING; METAL NANOPARTICLES; NANOPARTICLES; NANOSTRUCTURED MATERIALS; PROBES; SURFACE CHEMISTRY; ZETA POTENTIAL;

CHEMICAL FUNCTIONALITY; DRUG DELIVERY SYSTEM; HYDRODYNAMIC RADIUS; IRON OXIDE NANOPARTICLE; PHARMACOKINETIC STUDIES; RADIOLABELED PROBES; SURFACE FUNCTIONAL GROUPS; SURFACE FUNCTIONALITIES;

IRON OXIDES;

CARBON; CARBOXYLIC ACID; IRON; METAL NANOPARTICLE; OXIDE; POLYAMINE; SILICON;

ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CHEMISTRY; DRUG DELIVERY SYSTEM; FOURIER ANALYSIS; HYDRODYNAMICS; LIGHT; MALE; MOUSE; NANOTECHNOLOGY; RADIATION SCATTERING; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TISSUE DISTRIBUTION;

ANIMALS; CARBON; CARBOXYLIC ACIDS; CELL LINE; DRUG DELIVERY SYSTEMS; FOURIER ANALYSIS; HYDRODYNAMICS; IRON; LIGHT; MALE; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; NANOTECHNOLOGY; OXIDES; POLYAMINES; SCATTERING, RADIATION; SILICON; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 84926483455     PISSN: 20403364     EISSN: 20403372     Source Type: Journal    
DOI: 10.1039/c4nr06441k     Document Type: Article

References (59)

1. R. Urso P. Blardi G. Giorgi A short introduction to pharmacokinetics Eur. Rev. Med. Pharmacol. Sci. 2002 6 2-3 33 44
2. F. F. Hefti Requirements for a lead compound to become a clinical candidate BMC Neurosci. 2008 9 Suppl 3 S7
3. H. Ledford Drug candidates derailed in case of mistaken identity Nature 2012 483 7391 519
4. P. D. Nallathamby K. J. Lee X. H. Xu Design of stable and uniform single nanoparticle photonics for in vivo dynamics imaging of nanoenvironments of zebrafish embryonic fluids ACS Nano 2008 2 7 1371 1380
5. A. Astashkina B. Mann D. W. Grainger A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity Pharmacol. Ther. 2012 134 1 82 106
6. F. P. Guengerich Mechanisms of drug toxicity and relevance to pharmaceutical development Drug Metab. Pharmacokinet. 2011 26 1 3 14
7. J. M. McKim Jr. Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance Comb. Chem. High Throughput Screening 2010 13 2 188 206
8. S. S. Singh Preclinical pharmacokinetics: an approach towards safer and efficacious drugs Curr. Drug Metab. 2006 7 2 165 182
9. T. Maziasz et al., Predictive toxicology approaches for small molecule oncology drugs Toxicol. Pathol. 2010 38 1 148 164
10. M. Z. Ahmad et al., Metallic nanoparticles: technology overview & drug delivery applications in oncology Expert Opin. Drug Delivery 2010 7 8 927 942
11. S. M. Janib A. S. Moses J. A. MacKay Imaging and drug delivery using theranostic nanoparticles Adv. Drug Delivery Rev. 2010 62 11 1052 1063
12. D. Yoo et al., Theranostic Magnetic Nanoparticles Acc. Chem. Res. 2011 44 10 863 874
13. P. D. Nallathamby T. Huang X. H. Xu Design and characterization of optical nanorulers of single nanoparticles using optical microscopy and spectroscopy Nanoscale 2010 2 9 1715 1722
14. P. D. Nallathamby X. H. Xu Study of cytotoxic and therapeutic effects of stable and purified silver nanoparticles on tumor cells Nanoscale 2010 2 6 942 952
15. S. K. Nune et al., Nanoparticles for biomedical imaging Expert Opin. Drug Delivery 2009 6 11 1175 1194
16. G. Bao S. Mitragotri S. Tong Multifunctional Nanoparticles for Drug Delivery and Molecular Imaging Annu. Rev. Biomed. Eng. 2013 15 1 253 282
17. K. Tsaioun M. Jacewicz De-risking drug discovery with ADDME-avoiding drug development mistakes early ATLA, Altern. Lab. Anim. 2009 37 Suppl 1 47 55
18. J. Wang W. Gao Nano/Microscale motors: biomedical opportunities and challenges ACS Nano 2012 6 7 5745 5751
19. J. Leleux K. Roy Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective Adv. Healthc. Mater. 2013 2 1 72 94
20. S. Singh Nanomedicine-nanoscale drugs and delivery systems J. Nanosci. Nanotechnol. 2010 10 12 7906 7918
21. N. Kamaly et al., Targeted polymeric therapeutic nanoparticles: design, development and clinical translation Chem. Soc. Rev. 2012 41 7 2971 3010
22. K. J. Lee et al., Study of Charge-Dependent Transport and Toxicity of Peptide-Functionalized Silver Nanoparticles Using Zebrafish Embryos and Single Nanoparticle Plasmonic Spectroscopy Chem. Res. Toxicol. 2013 26 6 904 917
23. C. Tang et al., Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? Stem Cells 2010 28 9 1686 1702
24. F. M. Kievit M. Zhang Surface engineering of iron oxide nanoparticles for targeted cancer therapy Acc. Chem. Res. 2011 44 10 853 862
25. T. Sadhukha T. S. Wiedmann J. Panyam Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy Biomaterials 2013 34 21 5163 5171
26. C. Plank O. Zelphati O. Mykhaylyk Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects Adv. Drug Delivery Rev. 2011 63 14-15 1300 1331
27. L. O. Sillerud et al., SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AbetaPP/PS-1 transgenic mouse brain J. Alzheimers Dis. 2013 34 2 349 365
28. A. K. Gupta M. Gupta Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications Biomaterials 2005 26 18 3995 4021
29. R. Alwi et al., Silica-coated super paramagnetic iron oxide nanoparticles (SPION) as biocompatible contrast agent in biomedical photoacoustics Biomed. Opt. Express 2012 3 10 2500 2509
30. M. Mikhaylova et al., Superparamagnetism of magnetite nanoparticles: dependence on surface modification Langmuir 2004 20 6 2472 2477
31. M. Li et al., Physiologically based pharmacokinetic modeling of nanoparticles ACS Nano 2010 4 11 6303 6317
32. W. I. Hagens et al., What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul. Toxicol. Pharmacol. 2007 49 3 217 229
33. V. B. Mikheev et al., In vivo inhalation exposures to super-paramagnetic iron-oxide nano-particles (SPIONP) followed by magnetic particle detection (MPD) and accelerator mass spectrometry (AMS) analysis J. Aerosol Med. Pulm. Drug Delivery 2013 26 2 A16
34. J. Mitchell S. Newman H. K. Chan In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review AAPS PharmSciTech 2007 8 4 E110
35. C. Dunbar J. Mitchell Analysis of cascade impactor mass distributions J. Aerosol. Med. 2005 18 4 439 451
36. R. Hanas L. Lytzen J. Ludvigsson Thinner needles do not influence injection pain, insulin leakage or bleeding in children and adolescents with type 1 diabetes Pediatr. Diabetes 2000 1 3 142 149
37. F. C. Bersworth, Method of forming carboxylic amino acids, 1945, Google Patents
38. G. C. Kim W. Kim Charge-transfer surface complex of EDTA-TiO2 and its effect on photocatalysis under visible light Appl. Catal., B 2010 100 1-2 77 83
39. J. Ryczkowski FT-IR study of the adsorption of some complexones and of EDTA alkaline salts into alumina Vib. Spectrosc. 2000 22 1 55 62
40. G. Hasenpusch et al., Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung Pharm. Res. 2012 29 5 1308 1318
41. J. M. Hillegass et al., Assessing nanotoxicity in cells in vitro Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2010 2 3 219 231
42. S. R. Blumen et al., Unique uptake of acid-prepared mesoporous spheres by lung epithelial and mesothelioma cells Am. J. Respir. Cell Mol. Biol. 2007 36 3 333 342
43. R. P. Nishanth et al., Inflammatory responses of RAW 264.7 macrophages upon exposure to nanoparticles: role of ROS-NFkappaB signaling pathway Nanotoxicology 2011 5 4 502 516
44. S. Di Bucchianico et al., Multiple cytotoxic and genotoxic effects induced in vitro by differently shaped copper oxide nanomaterials Mutagenesis 2013 28 3 287 299
45. N. P. Mortensen et al., Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity Nanoscale 2013 5 14 6372 6380
46. M. Pretze P. Große-Gehling C. Mamat Cross-Coupling Reactions as Valuable Tool for the Preparation of PET Radiotracers Molecules 2011 16 2 1129 1165
47. H. Hong et al., Molecular imaging and therapy of cancer with radiolabeled nanoparticles Nano Today 2009 4 5 399 413
48. Y. Liu M. J. Welch Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications Bioconjugate Chem. 2012 23 4 671 682
49. K. Greish G. Thiagarajan H. Ghandehari In vivo methods of nanotoxicology Methods Mol. Biol. 2012 926 235 253
50. T. Huang et al., Design and synthesis of single-nanoparticle optical biosensors for imaging and characterization of single receptor molecules on single living cells Anal. Chem. 2007 79 20 7708 7718
51. C. Wangler et al., Click-chemistry reactions in radiopharmaceutical chemistry: fast & easy introduction of radiolabels into biomolecules for in vivo imaging Curr. Med. Chem. 2010 17 11 1092 1116
52. R. Rossin et al., 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation J. Nucl. Med. 2005 46 7 1210 1218
53. F. Staud et al., Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats J. Pharm. Sci. 1999 88 6 577 585
54. G. A. Bailey et al., H(2)azapa: a Versatile Acyclic Multifunctional Chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu Inorg. Chem. 2012 51 22 12575 12589
55. M. Longmire P. L. Choyke H. Kobayashi Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats Nanomedicine 2008 3 5 703 717
56. M. T. Zhu et al., Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment Toxicol. Sci. 2009 107 2 342 351
57. J. D. Slack et al., Acute hemodynamic effects and blood pool kinetics of polystyrene microspheres following intravenous administration J. Pharm. Sci. 1981 70 6 660 664
58. M. A. Malfatti et al., Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry Nano Lett. 2012 12 11 5532 5538
59. J. S. Vogel A. H. Love Quantitating isotopic molecular labels with accelerator mass spectrometry Methods Enzymol. 2005 402 402 422